跳至主要内容
临床试验/NCT07035067
NCT07035067终止不适用

Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada

PeriPharm2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2025年7月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
24
试验地点
2
主要终点
To estimate the quality of life of patient with ovarian cancer

研究概览

简要总结

Filling the gap in Canadian evidence on the burden of PROC on QoL is essential. It will help better understand the impact of PROC on multiple aspects of the lives of patients and their caregivers and the real-life hurdles faced by PROC patients and their caregivers. The outputs of this study will help better understand the hurdles and challenges they face and the significant unmet medical need.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient Inclusion Criteria
  • ≥18 years old
  • Patients with PROC who received >1 prior line of therapy identified through a screening survey. PROC will be defined as recurrence less than 6 months after last platinum chemotherapy (i.e. carboplatin or cisplatin)
  • Ability to read and understand French or English
  • Signature of ICF

排除标准

  • Patients with PSOC, defined as those who:
  • Have not progressed within less than 6 months after completion of platinum-based chemotherapy or;
  • Are still on platinum chemotherapy or;
  • Receive maintenance therapy.
  • Patients with platinum-refractory ovarian cancer, defined as not responding or disease progressing during therapy or within three months after the last dose
  • Caregivers Inclusion Criteria:
  • ≥18 years old
  • Current caregiver of a patient with PROC (see definition to be used above) who received >1 prior line of therapy identified through a screening survey.
  • Ability to read and understand French or English
  • Signature of ICF.
  • Caregivers Exclusion Criteria:
  • Caregivers of patients with PSOC (see definition above)
  • Caregivers of PROC patients who have passed away
  • Caregivers of platinum-refractory patients (see definition above)

研究组 & 干预措施

Caregiver of PROC patients part of Ovarian Cancer Canada mailing lists

干预措施: No intervention (Other)

Patients with PROC part of Ovarian Cancer Canada mailing lists

干预措施: No intervention (Other)

结局指标

主要结局

To estimate the quality of life of patient with ovarian cancer

时间窗: At recruitment

Using the the Functional Assessment of Cancer Therapy - Ovarian (FACT-O) and EuroQol 5-dimendion 5-level (EQ-5D-5L)

次要结局

  • Patient's symptoms assessment(At recruitment)
  • Caregiver's Quality of Life(At recruitment)
  • Patients and caregivers work productivity loss and activity impairment(At recruitment)
  • Patient's preference in treatment(At recruitment)

研究者

发起方
PeriPharm
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验